The October 1, 2023 Pharmaceutical Benefits Scheme (PBS) listing of a new, once-daily, oral treatment for severe chronic plaque psoriasis represents good news for the estimated 19,000 Australian adults living with the common inflammatory skin disease. At VIVA! Communications, we are proud to be supporting the communication of this PBS listing announcement, working in partnership…

Read More